Wednesday, July 8, 2026

Drug profile · INN

sevoflurane

sevoflurane (SEVOFLURANE) is a potassium channel subfamily k member 2 opener. Route of administration: inhalation. Current US regulatory status: approved.

FDA: approved NMPA: clinical trials
US status approved
Patents linked 7
Pipeline programs 10
News articles 0
Drug details — sevoflurane
US status
approved
Class
Route
INHALATION
Patents
7
Programs
10
Data quality
0.84

Quick answer

sevoflurane (SEVOFLURANE) is a potassium channel subfamily k member 2 opener. Route of administration: inhalation. Current US regulatory status: approved.

Key facts

INN sevoflurane
Brand SEVOFLURANE
Mechanism Potassium channel subfamily K member 2 opener
Target GABA-A receptor; anion channel
Route INHALATION
Formulation LIQUID

Mechanism of action

Potassium channel subfamily K member 2 opener

Primary target: GABA-A receptor; anion channel

Approval history

Authority Status Date
FDA approved
NMPA clinical trials

Pipeline programs

  1. HSK3486-309 Phase 3 · Anaxis Pharma · General anaesthesia
  2. SEVOFLURANE, DEXMEDETOMIDINE HYDROCHLORIDE Phase 3 · George Institute for · Children under the age of 2 years having surgery lasting at
  3. Sevoflurane Phase 3 · Universal Integrated · Anesthesia
  4. SIMA SPK 01 Approved · George Institute for · End-stage kidney disease in Type 1 diabetes, SIROLIMUS VERSU
  5. Sevoflurane Approved · Chinese Academy of · Middle Aged Patients
  6. Sevoflurane Approved · Chinese Academy of · Intra-abdominal and Intrapelvic Surgery
  7. 1.0 /2024.05.01 Unknown · First People's Hospital · Gastrointestinal Stromal Tumors
  8. Sevoflurane Unknown · First People's Hospital · Liver Transplantation

Related & competitor drugs

  1. acamprosate calcium GABA-A receptor; anion channel positive modulator
  2. alprazolam GABA-A receptor; anion channel positive allosteric modulator
  3. butabarbital sodium GABA-A receptor; anion channel positive allosteric modulator
  4. chlordiazepoxide hydrochloride GABA-A receptor; anion channel positive allosteric modulator
  5. clobazam GABA-A receptor; anion channel positive allosteric modulator
  6. clonazepam GABA-A receptor; anion channel positive allosteric modulator

Related patents

  1. US 11061094

    Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. DE 102019218589

    Simultane Bilddarstellung von zwei unterschiedlichen funktionellen Bereichen

    Expires Tue May 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 9119828

    Antibodies with simultaneous subsite specificities to protein and lipid epitopes

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 8691967

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 8283461

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7727970

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7572124

    Apparatus for simultaneous illumination of teeth

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sevoflurane?

sevoflurane (SEVOFLURANE) is a potassium channel subfamily k member 2 opener. Route of administration: inhalation. Current US regulatory status: approved.

What is the brand name for sevoflurane?

SEVOFLURANE is a marketed brand name for sevoflurane. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sevoflurane?

sevoflurane has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.